{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:04:31Z","timestamp":1785877471432,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-17-IBS-296"],"award-info":[{"award-number":["1-17-IBS-296"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2019YJ0062"],"award-info":[{"award-number":["2019YJ0062"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.mce.2019.110642","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T19:48:08Z","timestamp":1574279288000},"page":"110642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Empagliflozin attenuates ischemia and reperfusion injury through LKB1\/AMPK signaling pathway"],"prefix":"10.1016","volume":"501","author":[{"given":"Qingguo","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5395-3660","authenticated-orcid":false,"given":"Nanwei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0899-4412","authenticated-orcid":false,"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2019.110642_bib1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3389\/fphys.2017.01077","article-title":"Empagliflozin limits myocardial infarction in vivo and cell death in vitro: role of STAT3, mitochondria, and redox aspects","volume":"8","author":"Andreadou","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.mce.2019.110642_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)\/H(+) exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.mce.2019.110642_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvx149","article-title":"Cardiac effects of SGLT2 inhibitors: the sodium hypothesis","volume":"114","author":"Bertero","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.110642_bib4","doi-asserted-by":"crossref","first-page":"H239","DOI":"10.1152\/ajpheart.01269.2005","article-title":"AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B","volume":"291","author":"Bertrand","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2019.110642_bib5","article-title":"The effects of empagliflozin, an SGLT2 inhibitor, on pancreatic beta-cell mass and glucose homeostasis in type 1 diabetes","volume":"11","author":"Cheng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2019.110642_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.metabol.2018.03.004","article-title":"Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-kappaB pathway","volume":"83","author":"Chen","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.mce.2019.110642_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(78)90500-7","article-title":"Transluminal dilatation of coronary-artery stenosis","volume":"1","author":"Gruntzig","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2019.110642_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10557-017-6734-1","article-title":"Empagliflozin improves left ventricular diastolic dysfunction in a genetic model of type 2 diabetes","volume":"31","author":"Hammoudi","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.mce.2019.110642_bib11","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1242\/jcs.01540","article-title":"The AMP-activated protein kinase pathway--new players upstream and downstream","volume":"117","author":"Hardie","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mce.2019.110642_bib12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1432-1033.1997.00259.x","article-title":"The AMP-activated protein kinase--fuel gauge of the mammalian cell?","volume":"246","author":"Hardie","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.mce.2019.110642_bib13","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\/Glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2019.110642_bib14","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db12-0533","article-title":"Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes","volume":"62","author":"He","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.mce.2019.110642_bib15","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.18632\/aging.101910","article-title":"Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA\/LKB1\/AMPK pathway","volume":"11","author":"Huang","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.mce.2019.110642_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.117.029190","volume":"136","author":"Kosiborod","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2019.110642_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mce.2019.110642_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-014-0148-1","article-title":"Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice","volume":"13","author":"Lin","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.mce.2019.110642_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/toxsci\/kfy272","article-title":"Dichloroacetate ameliorates cardiac dysfunction caused by ischemic insults through AMPK signal pathway- not only shifts metabolism","volume":"167","author":"Li","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.mce.2019.110642_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.110.953208","article-title":"Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart","volume":"122","author":"Ma","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2019.110642_bib21","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1038\/s41598-018-23420-4","article-title":"Canagliflozin inhibits interleukin-1beta-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms","volume":"8","author":"Mancini","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2019.110642_bib22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/j.2040-4603.2015.tb00621.x","article-title":"Metabolic shifts during aging and pathology","volume":"5","author":"Ma","year":"2015","journal-title":"Comp. Physiol."},{"key":"10.1016\/j.mce.2019.110642_bib23","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1161\/CIRCULATIONAHA.109.913350","article-title":"Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data","volume":"122","author":"Mazzone","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2019.110642_bib24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nature06504","article-title":"Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart","volume":"451","author":"Miller","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.mce.2019.110642_bib25","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1096\/fj.14-258814","article-title":"Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart","volume":"29","author":"Morrison","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.mce.2019.110642_bib26","doi-asserted-by":"crossref","first-page":"H895","DOI":"10.1152\/ajpheart.00137.2011","article-title":"Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice","volume":"301","author":"Morrison","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2019.110642_bib27","doi-asserted-by":"crossref","first-page":"H887","DOI":"10.1152\/ajpheart.00750.2008","article-title":"Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1","volume":"296","author":"Moshal","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.mce.2019.110642_bib28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2019.110642_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054442","article-title":"Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?","volume":"8","author":"Panchapakesan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2019.110642_bib30","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1096\/fj.201700063R","article-title":"Sestrin2 prevents age-related intolerance to ischemia and reperfusion injury by modulating substrate metabolism","volume":"31","author":"Quan","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.mce.2019.110642_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2019.110642_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1172\/JCI19297","article-title":"AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury","volume":"114","author":"Russell","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mce.2019.110642_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/toxsci\/kfw154","article-title":"Cardiac-Specific deletion of the Pdha1 gene sensitizes heart to toxicological actions of ischemic stress","volume":"153","author":"Sun","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.mce.2019.110642_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jphs.2016.02.003","article-title":"Characterization and comparison of sodium-glucose cotransporter 2 inhibitors in pharmacokinetics, pharmacodynamics, and pharmacologic effects","volume":"130","author":"Tahara","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.mce.2019.110642_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/CIRCULATIONAHA.112.000862","article-title":"Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction","volume":"128","author":"Wang","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2019.110642_bib36","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1538-7836.2011.04331.x","article-title":"Activated protein C protects against myocardial ischemic\/reperfusion injury through AMP-activated protein kinase signaling","volume":"9","author":"Wang","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.mce.2019.110642_bib37","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/cvr\/cvy033","article-title":"Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury","volume":"114","author":"Wang","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2019.110642_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2019.110642_bib39","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1074\/jbc.M511178200","article-title":"Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells","volume":"281","author":"Xie","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2019.110642_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bcp.2016.03.019","article-title":"Cardioprotective actions of Notch1 against myocardial infarction via LKB1-dependent AMPK signaling pathway","volume":"108","author":"Yang","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2019.110642_bib41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10557-017-6725-2","article-title":"SGLT-2 inhibition with dapagliflozin reduces the activation of the Nlrp3\/ASC inflammasome and attenuates the development of diabetic cardiomyopathy in mice with type 2 diabetes. Further augmentation of the effects with Saxagliptin, a DPP4 inhibitor","volume":"31","author":"Ye","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.mce.2019.110642_bib42","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbrc.2017.08.034","article-title":"The endotoxemia cardiac dysfunction is attenuated by AMPK\/mTOR signaling pathway regulating autophagy","volume":"492","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2019.110642_bib43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.redox.2017.12.019","article-title":"Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission","volume":"15","author":"Zhou","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.mce.2019.110642_bib44","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1159\/000475942","article-title":"The sodium-glucose Co-transporter 2 inhibitor, empagliflozin, protects against diabetic cardiomyopathy by inhibition of the endoplasmic reticulum stress pathway","volume":"41","author":"Zhou","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.mce.2019.110642_bib45","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720719303442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720719303442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:10:36Z","timestamp":1759587036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720719303442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":43,"alternative-id":["S0303720719303442"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2019.110642","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin attenuates ischemia and reperfusion injury through LKB1\/AMPK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2019.110642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110642"}}